More than 4,000 British Columbians will be diagnosed with breast cancer this year. They will experience some of the best outcomes in the world. Many will be cured.
But cancer is relentless, and there are breast cancer subtypes that continue to evade treatment. Right now, we have a $20 million goal to break down women’s cancers, including rare and hard to treat breast cancers.
Over the past decade, under the leadership of Dr. Samuel Aparicio, BC Cancer has delivered world first discoveries in breast cancer that have transformed the way the disease is treated today. They are global leaders in producing landmark publications and are the most widely cited research group in the world on breast cancer.
The team discovered 10 unique sub-types of breast cancer, decoding the genomic structure of the most deadly of these, and proving that cancer has the ability to change over time and in response to treatments.
"We will be able to personalize and refine treatments based on what individual patients need."
Dr. Sam Aparicio, BC Cancer
Now, they’ve launched B-PRECISE. Individuals facing breast cancer in B.C. can actively take part in B-PRECISE. The key focus is tackling unmet medical needs and bringing precision medicine to patients, in particular those with rare and hard to treat sub-types.
B-PRECISE will answer the toughest questions plaguing breast cancer researchers and clinicians to find better solutions for patients.
This year, approximately 250 men will be diagnosed with breast cancer in Canada. Although rare, men need to be aware of symptoms. If you feel a lump consult with your trusted clinician.